CLINICAL TRIALS PROFILE FOR LIDODERM
✉ Email this page to a colleague
505(b)(2) Clinical Trials for Lidoderm
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT02749123 ↗ | Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis | Unknown status | J.A.R. Laboratories | N/A | 2016-04-01 | A comparison of transdermal patches for efficacy, side effects and quality of life for patients with back pain and arthritis. The three arms in the trial were; prescription strength lidocaine 5%, over the counter lidocaine 3.6%, menthol 1.25% and placebo. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Lidoderm
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00266214 ↗ | Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome | Terminated | Endo Pharmaceuticals | Phase 3 | 2005-11-01 | The purpose of this study is to evaluate the analgesic efficacy and safety of the lidocaine patch 5% compared to placebo in patients with moderate to severe pain associated with carpal tunnel syndrome. |
| NCT00414453 ↗ | Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis | Terminated | Endo Pharmaceuticals | Phase 4 | 2007-01-01 | This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology. |
| NCT00414453 ↗ | Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis | Terminated | University of Rochester | Phase 4 | 2007-01-01 | This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology. |
| NCT00589979 ↗ | Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee | Completed | Endo Pharmaceuticals | Phase 2 | 2007-03-01 | Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from their current analgesic regimen will participate in a pilot clinical trial to evaluate the effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee pain from OA. |
| NCT00659633 ↗ | The Effect of Intravenous Lidocaine on Allodynia | Completed | American Society of Regional Anesthesia | N/A | 2008-12-01 | The purpose of this study is to study if lidocaine, given intravenously, reduces pain. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lidoderm
Condition Name
Clinical Trial Locations for Lidoderm
Trials by Country
Clinical Trial Progress for Lidoderm
Clinical Trial Phase
Clinical Trial Sponsors for Lidoderm
Sponsor Name
